ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 154 filers reported holding ARRAY BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $605,000 | +260.1% | 13,080 | +10.8% | 0.00% | – |
| Q4 2018 | $168,000 | +3.1% | 11,808 | +9.7% | 0.00% | -100.0% |
| Q3 2018 | $163,000 | -74.5% | 10,763 | -71.7% | 0.00% | -66.7% |
| Q2 2018 | $639,000 | +2562.5% | 38,087 | +2400.8% | 0.00% | +200.0% |
| Q1 2018 | $24,000 | -93.1% | 1,523 | -96.3% | 0.00% | -93.3% |
| Q2 2017 | $348,000 | +3063.6% | 41,613 | +3269.5% | 0.02% | – |
| Q1 2017 | $11,000 | -92.4% | 1,235 | -96.4% | 0.00% | -100.0% |
| Q4 2015 | $145,000 | +30.6% | 34,411 | +126.6% | 0.01% | -15.4% |
| Q1 2015 | $111,000 | +26.1% | 15,186 | -17.9% | 0.01% | +18.2% |
| Q4 2014 | $88,000 | – | 18,508 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |